Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: results of a multicentr (Q44712612)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: results of a multicentr |
scientific article |
Statements
1 reference
Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: results of a multicentr (English)
1 reference
1 reference
Julie Vose
1 reference
Owen A O'Connor
1 reference
Craig Moskowitz
1 reference
Carol Portlock
1 reference
David Straus
1 reference
Otilia Dumitrescu
1 reference
Mithat Gonen
1 reference
John Butos
1 reference
Ellen Neylon
1 reference
Barbara Mac-Gregor Cortelli
1 reference
Susan Blumel
1 reference
John J Wright
1 reference
Brenda Cooper
1 reference
Jane Winter
1 reference
6 February 2009
1 reference
1 reference
Identifiers
1 reference